[1]
J. R. Vazquez-Urrutia, N. Venugopal, J. Zhu, and T. Komiya, “Incidence and Prognostic Value of TP53, STK11, and KEAP1 Mutations Between De Novo Versus Recurrent Actionable Mutation–Negative Non-Small Cell Lung Cancer: A Single-Center Retrospective Study”, World J Oncol, vol. 17, no. 3, pp. 310–321, Jan. 2026, doi: 10.14740/wjon2761.